Pharmacokinetics of flunixin meglumine in donkeys, mules, and horses

American Journal of Veterinary Research

Volumn 60, Issue 11, 1999, Pages 1441-1444

  Coakley, Mariah ^a   Peck, Kenneth E ^a   Taylor, Tex S ^a   Matthews, Nora S ^a   Mealey, Katrina L ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUNIXIN MEGLUMINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DONKEY; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; INFLAMMATION; NONHUMAN;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; CLONIXIN; EQUIDAE; FEMALE; HORSES; INJECTIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; SPECIES SPECIFICITY; TIME FACTORS;

ANIMALIA; EQUIDAE; EQUUS ASINUS; EQUUS CABALLUS;

EID: 0032710579     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Lees P, Ewins CP, Taylor BO, et al. Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone, and flunixin. Br Vet J 1987;143:462-476.
2. Semrad SD, Hardee GE, Hardee MS, et al. Flunixin meglumine given in small doses: pharmacokinetics and prostaglandin inhibition in healthy horses. Am J Vet Res 1985;46:2474-2479.
3. Lees P, Higgins AJ. Clinical pharmacology and therapeutic uses of nonsteroidal anti-inflammatory drugs in the horse. Equine Vet J 1985;17:83-96.
4. MacAllister CG, Morgan SJ, Borne AT, et al. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. J Am Vet Med Assoc 1993;202:71-77.
5. Kallings P. Nonsteroidal anti-inflammatory drugs Vet Clin North Am Equine Pract 1993;9:523-541.
6. Mealey K, Matthews N, Peck K, et al. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys. Am J Vet Res 1997;58:53-55.
7. Welfare R, Mealey K, Matthews N, et al. Pharmacokinetics of gentamicin in donkeys. J Vet Pharmacol Therap 1996;19:167-169.
8. Matthews N, Taylor T, Hartsfield S, et al. Pharmacokinetics of ketamine in mules and mammoth asses premedicated with xylazine. Equine Vet J 1994;26:241-243.
9. Oukessou M, Boulijihad M, Van Gool F, et al. Pharmacokinetics of ketoprofen in the donkey (Equus asinus). Zentralbl Veterinarmed [A] 1996;43:423-426.
10. Soma L, Behrend E, Rudy J, et al. Disposition and excretion of flunixin meglumine in horses. Am J Vet Res 1988;49: 1894-1898.
11. Semrad SD, Hardee GE, Hardee MS, et al. Flunixin meglumine given in small doses: pharmacokinetics and prostaglandin inhibition in healthy horses. Am J Vet Res 1985;46:2474-2479.
12. Cheng Z, McKellar Q, Nolan A, et al. Preliminary pharmacokinetic and pharmacodynamic studies on flunixin meglumine in donkeys. Vet Res Commun 1996;20:469-472.
13. Peck KE, Ray AC, Manual G, et al. Quantification of phenylbutazone in equine sera by use of high-performance liquid chromatography with a nonevaporative extraction technique. Am J Vet Res 1996;57:1522-1524.